Reduction mammaplasty in patients with history of breast cancer: The incidence of occult cancer and high-risk lesions.

Breast (Edinburgh, Scotland) 2017 Vol.35() p. 157-161

Merkkola-von Schantz PA, Jahkola TA, Krogerus LA, Kauhanen SMC

관련 도메인

Abstract

[INTRODUCTION] Contralateral reduction mammaplasty is regularly included in the treatment of breast cancer patients. We analyzed the incidence of occult breast cancer and high-risk lesions in reduction mammaplasty specimens of women with previous breast cancer. We also analyzed if timing of reduction mammaplasty in relation to oncological treatment influenced the incidence of abnormal findings, and compared if patients with abnormal contralateral histopathology differed from the study population in terms of demographics.

[MATERIALS AND METHODS] The study consisted of 329 breast cancer patients, who underwent symmetrizing reduction mammaplasty between 1/2007 and 12/2011. The data was retrospectively analyzed for demographics, operative and histopathology reports, oncological treatment, and postoperative follow-up.

[RESULTS] Reduction mammaplasty specimens revealed abnormal findings in 68 (21.5%) patients. High-risk lesions (ADH, ALH, and LCIS) were revealed in 37 (11.7%), and cancer in six (1.9%) patients. Abnormal histopathology correlated with higher age (p = 0.0053), heavier specimen (p = 0.0491), and with no previous breast surgery (p < 0.001). Abnormal histopathological findings were more frequent in patients with reduction mammaplasty performed prior to oncological treatment (p < 0.001), and in patients with immediate reconstruction (p = 0.0064).

[CONCLUSION] The incidences of malignant and high-risk lesions are doubled compared to patients without prior breast cancer. Patients with abnormal histopathology cannot be preoperatively identified based on demographics. If reduction mammaplasty is performed before oncological treatment, the incidence of abnormal findings is higher. In the light of our results, contralateral reduction mammaplasty with histopathological evaluation in breast cancer patients offers a sophisticated tool to catch those patients whose contralateral breast needs increased attention.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 mammaplasty 유방성형술 dict 9
해부 breast 유방 dict 9
합병증 lesions scispacy 1
약물 [INTRODUCTION] Contralateral scispacy 1
질환 breast cancer C0006142
Malignant neoplasm of breast
scispacy 1
질환 occult cancer C0741885
occult malignancy
scispacy 1
질환 Contralateral reduction scispacy 1
질환 ALH C1368920
Atypical Lobular Breast Hyperplasia
scispacy 1
질환 LCIS C0334381
Non-infiltrating lobular carcinoma
scispacy 1
질환 cancer C0006826
Malignant Neoplasms
scispacy 1
질환 breast cancer patients scispacy 1
기타 patients scispacy 1
기타 women scispacy 1
기타 ADH scispacy 1

MeSH Terms

Adult; Age Factors; Breast Neoplasms; Female; Follow-Up Studies; Humans; Incidental Findings; Mammaplasty; Middle Aged; Neoplasm Invasiveness; Retrospective Studies; Risk Factors

📑 인용 관계

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문